Risk Malignancy Index (RMI) in patients with abnormal pelvic mass: Comparing RMI 1, 2 and 3 in an Australian population.
Kader Ali Mohan
Ganendra Raj
GR
Department of Gynaecologic Oncology, Hunter New England Centre for Gynaecological Cancer, John Hunter Hospital, Newcastle, New South Wales, Australia. ganendraraj@hotmail.com
Jaaback
Kenneth
K
Proietto
Anthony
A
Robertson
Randall
R
Angstetra
Donald
D
D000005:Abdomen / Q000000981:diagnostic imaging; D000328:Adult; D001315:Australia; D018394:CA-125 Antigen / Q000097:blood; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D010048:Ovarian Cysts / Q000175:diagnosis* / Q000000981:diagnostic imaging; D010051:Ovarian Neoplasms / Q000175:diagnosis* / Q000000981:diagnostic imaging; D012017:Referral and Consultation; D018570:Risk Assessment / Q000379:methods; D014218:Triage / Q000379:methods*; D014463:Ultrasonography
D018394:CA-125 Antigen